Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bacterial cell wall and cell surface structures are essential components that provide structural support, protection, and environmental interaction for bacteria. The primary structural element is peptidoglycan, a cross-linked polymer of sugars and amino acids that maintains cell shape and prevents osmotic lysis (1.2.1, 1.3.4). In Gram-negative bacteria, the cell wall is further protected by an outer membrane containing lipopolysaccharides (LPS), which act as a permeability barrier and a potent endotoxin (1.3.5, 1.4.4). Other critical structures include teichoic acids in Gram-positive bacteria, which are involved in cell wall maintenance and virulence (1.1.1, 1.2.2). These structures are among the most successful targets in antimicrobial therapy because they are unique to bacteria and absent in human cells, ensuring high selective toxicity (1.3.1, 1.4.4). Antibiotics such as beta-lactams and glycopeptides disrupt peptidoglycan synthesis, leading to cell death, while polymyxins target the outer membrane of Gram-negative species (1.4.3, 1.4.5). However, the clinical utility of these drugs is increasingly threatened by the emergence of multidrug-resistant (MDR) pathogens and the potential for systemic inflammatory responses triggered by the release of cell wall fragments during treatment (1.2.1, 1.2.4).
Inhibition of peptidoglycan synthesis by binding to penicillin-binding proteins (PBPs) or sequestering precursors like Lipid II; disruption of membrane integrity through detergent-like interaction with lipopolysaccharides; inhibition of cell wall precursor transport across the cytoplasmic membrane.
12 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial cell wall and cell surface structures.